Eosinophilic Gastrointestinal Disorders Registry
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Study ID
- NCT05199532
- Status
- Recruiting
Conditions
- Eosinophilic Colitis
- Eosinophilic Esophagitis
- Eosinophilic Gastroenteritis
- Eosinophilic Gastrointestinal Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 25 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to learn more about Eosinophilic Gastrointestinal Disorders (EGIDs). With this registry we hope to find out more about the symptoms that patients have during their treatment, the quality of life they have with the diagnosis, what the disease looks like throughout the different treatment methods, and if there is a connection between EGIDs and connective tissue disorders. The goal of this study is to be able to better understand EGIDs and use information gained from all the information collected on this study for more precise treatments in the future. We want to create a large collection of samples, called a biorepository, to learn the most about EGIDs as possible. When the samples are collected, which will occur at procedures directed by your child's doctor as part of their standard of care, they will be stored for an unlimited amount of time to perform experiments on these samples and to gather information about EGIDs
Key Dates
- Start date
- Dec 18, 2020
- Status verified
- Mar 2026
- Primary completion
- Nov 30, 2030
- Completion
- Dec 31, 2035
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Clinical/Patient-Reported Measures [ Time Frame: through study completion, an average of 6 months to 1 year ]
Central Contacts
- Angela Anthony312-227-4559
- Mary Riordan312-227-4558
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | Joshua B Wechsler, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chicago, IL
Related Studies
- OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesRecruiting · Children's Hospital Medical Center, Cincinnati · Phoenix, Arizona
- A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksPHASE2 · Recruiting · Phathom Pharmaceuticals, Inc. · Little Rock, Arkansas
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruiting · Sanford Health · Sioux Falls, South Dakota
- Molecular Basis of Food AllergyEnrolling By Invitation · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania